Hemophagocytic syndrome (HPS) is a clinicopathological entity characterized by
histiocytic proliferation, with marked hemophagocytosis in the reticuloendothelial organs.
HPS caused by lymphoma is termed lymphoma-associated hemophagocytic syndrome (LAHS), and
there are few reports on canine and feline LAHS. The objective of this study was to
examine the clinical, diagnostic, and clinicopathologic features of LAHS in six dogs. The
diagnostic criteria of LAHS consisted of lymphoma, bicytopenia or pancytopenia in the
blood, and increased hemophagocytosis in the reticuloendothelial organs. In one dog, an
ocular form of lymphoma was recognized. A splenic form was recognized in two dogs, and a
hepatosplenic form was recognized in three dogs. Immunophenotyping revealed T-cell origin
in five dogs and B-cell origin in one dog by polymerase chain reaction for antigen
receptor rearrangement analysis. Nonspecific esterase stain was performed to differentiate
between neoplastic lymphocytes and hemophagocytes. All five dogs with T-cell lymphoma were
diagnosed with large granular lymphocyte (LGL) lymphoma. In three cases, palliative
therapy with glucocorticoids was conducted, while the other three cases received
chemotherapy as well. The survival times for the three dogs with glucocorticoids only were
6, 6, and 10 days and were 30, 54, and 68 days for the three treated with anticancer
therapy. The median survival time for the dogs was 20 days. This report indicates that
canine LAHS is likely to be caused by LGL lymphoma, and it has an aggressive behavior and
poor general prognosis, as seen in humans.